Wockhardt Limited
NSE: WOCKPHARMA.NS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- National Stock Exchange of India
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Habil Fakhruddin Khorakiwala
- Employees
- 2,386
- Headquarters
- Mumbai, India
- IPO year
- 2002
- Market cap
- ₹261.0B
- Website
- https://www.wockhardt.com
Loading WOCKPHARMA…
Loading profile data…Frequently asked questions about WOCKPHARMA
What does Wockhardt Limited (WOCKPHARMA.NS) do?
Wockhardt Limited, a pharmaceutical and biotechnology company, manufactures and markets active pharmaceutical ingredients, formulations, bio-similars, and vaccines in India, the United States, the United Kingdom, Ireland, Mexico, Russia, and internationally. It develops various molecules primarily in the areas of infectious diseases, such as WCK...
Where does WOCKPHARMA.NS trade?
Wockhardt Limited (WOCKPHARMA.NS) trades on the National Stock Exchange of India.
What sector is WOCKPHARMA.NS in?
Wockhardt Limited (WOCKPHARMA.NS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Wockhardt Limited?
Habil Fakhruddin Khorakiwala is the chief executive officer of Wockhardt Limited (WOCKPHARMA.NS).
Where is Wockhardt Limited headquartered?
Wockhardt Limited is headquartered in India.
Does WOCKPHARMA.NS pay a dividend?
Wockhardt Limited (WOCKPHARMA.NS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WOCKPHARMA.NS go public?
Wockhardt Limited (WOCKPHARMA.NS) completed its initial public offering in 2002.